---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-034874"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:37:48.050020+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Health announces preliminary Q2 2025 revenue of $10.1-10.2M, up 41-42% YoY

## Summary
- Preliminary Q2 2025 revenue $10.1-10.2M, increase 41-42% over Q2 2024.
- First half 2025 revenue up 50-51% vs first half 2024.
- Revenue within range of guidance provided in Q1 2025 earnings release.
- CEO Morgan Frank notes sales team expanded to 13, covering all national territories for first time.
- Full Q2 results expected on or around August 8, 2025.

## SEC filing metadata
- accession: 0001628280-25-034874
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000162828025034874/0001628280-25-034874-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000162828025034874/snwv-20250714.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-034874
- JSON: https://secwatch.observer/filing/0001628280-25-034874.json
- Plain text: https://secwatch.observer/filing/0001628280-25-034874.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.